Moderna aims to price coronavirus vaccine at $50-$60 per course: Report

Industry analysts said Pfizer and BioNTech’s $2 billion deal to cover 50 million patients, which is contingent on an approvable product, would likely pressure other manufacturers to set similar prices.

from Hindustan Times - world https://bit.ly/307GesN
https://ift.tt/2zbki14